Benjamin Terrier, MD, PhD

Cochin Hospital
Paris, France

Professor of Internal Medicine in Paris, France

Disclosure information not submitted.

Presentation(s):

• 0527: Rituximab as Maintenance Therapy for ANCA-associated Vasculitides: Pooled Analysis and Long-term Outcome of MAINRITSAN Trials

  Saturday, November 12, 2022
  3:45 PM – 3:55 PM Eastern Time

• 0557: VEXAS Syndrome Is Characterized by Blood and Tissues Inflammasome Pathway Activation and Monocyte Dysregulation

  Saturday, November 12, 2022
  5:45 PM – 5:55 PM Eastern Time

• 1080: Performance of Risk Prediction Models for Relapse and Severe Infection at the End of 18-month Rituximab Maintenance Therapy in ANCA-associated Vasculitides: Data from the MAINRITSAN Trials

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 576: CH Vasculitis: Cryoglobulinemic Vasculitis: An Update and Small-Vessel Vasculitis Abstract Lightening Review

  Sunday, November 13, 2022
  1:00 PM – 2:00 PM Eastern Time

• Press Conference: Improving Rheumatology Patient Outcomes

  Monday, November 14, 2022
  8:00 AM – 9:00 AM Eastern Time

• L16: Innovative Anti-pneumococcal Vaccine Strategies versus Standard Vaccination Regimen in Patients with ANCA-associated Vasculitides Receiving Rituximab Therapy: A Multicenter Randomized Controlled Trial (PNEUMOVAS)

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• L16: Innovative Anti-pneumococcal Vaccine Strategies versus Standard Vaccination Regimen in Patients with ANCA-associated Vasculitides Receiving Rituximab Therapy: A Multicenter Randomized Controlled Trial (PNEUMOVAS)

  Monday, November 14, 2022
  2:45 PM – 2:50 PM Eastern Time

• 2232: Clinical Features and Long-term Outcomes of Patients with Systemic Polyarteritis Nodosa Diagnosed Since 2005: Data from 196 Patients

  Monday, November 14, 2022
  4:15 PM – 4:25 PM Eastern Time